Stockreport

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results

Eledon Pharmaceuticals, Inc.  (ELDN) 
PDF Presented updated data on 13 participants from ongoing Phase 1b trial evaluating tegoprubart for prevention of rejection in kidney transplantation 80 participants (tw [Read more]